Language selection

Search

Funding to advance Canada's countermeasures in the fight against COVID-19

From: Innovation, Science and Economic Development Canada

Further to the Government's announcement on April 23, 2020, the Strategic Innovation Fund will support projects to advance Canada's medical countermeasures in the fight against COVID-19. This includes support for COVID-19 related vaccine and therapy clinical trials led by the private sector, and Canadian bio-manufacturing opportunities.

Vaccines and Therapies

As we continue to assess funding requests received to date, we would like to hear from you if you are developing COVID-19 vaccines and therapies and are seeking funding to support clinical trials. If you are currently in the early-stages of development, and are seeking support for discovery and pre-clinical research, we recommend that you visit the Innovation Canada platform to identify the most suitable program for you.

If you are an entity incorporated in Canada currently advancing the development of a vaccine or therapy for COVID-19, please send an email to ic.sifintegrationteam-equipeintegration-fsi.ic@canada.ca with the subject line "COVID-19 MCMs". In a short email, please provide the following information:

Bio-manufacturing

If you are an entity incorporated in Canada that has a project that expands domestic bio-manufacturing capacity related to COVID-19, please send an email to ic.sifadmission-fsiadmission.ic@canada.ca and the SOI package will automatically be sent to you via e-mail.

For any inquiries, we encourage you to contact the SIF Integration Team at the following address: ic.sifintegrationteam-equipeintegration-fsi.ic@canada.ca. Thank you for your interest.

April 23, 2020 Announcement

Date modified: